Inventor · disambiguated record
David Heslin
Also filed as: HESLIN DAVID · HESLIN DAVID JONATHAN
9 granted patents·3 pending applications·190 citations·filing 2010–2020
89Inventor score
Files withREGENERON PHARMA12
Top patents by PatentIndex Score
12 records- 0198US10329582B2Genetic modification of ratsREGENERON PHARMA·Filed 2016·Granted Jun 25, 2019·25 cites·37 claims
- 0298US8697851B2MiRNA-regulated differentiation-dependent self-deleting cassetteREGENERON PHARMA·Filed 2012·Granted Apr 15, 2014·91 cites·9 claims
- 0398US8354389B2miRNA-regulated differentiation-dependent self-deleting cassetteREGENERON PHARMA·Filed 2010·Granted Jan 15, 2013·56 cites·13 claims
- 0492US9267152B2MiRNA-regulated differentiation-dependent self-deleting cassetteREGENERON PHARMA·Filed 2015·Granted Feb 23, 2016·4 cites·29 claims
- 0590US9096870B2miRNA-regulated differentiation-dependent self-deleting cassetteREGENERON PHARMA·Filed 2014·Granted Aug 4, 2015·6 cites·13 claims
- 0689US10781453B2Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locusREGENERON PHARMA·Filed 2017·Granted Sep 22, 2020·6 cites·48 claims
- 0788US10894965B2Genetic modification of ratsREGENERON PHARMA·Filed 2019·Granted Jan 19, 2021·2 cites·39 claims
- 0876US12065661B2Genetic modification of ratsREGENERON PHARMA·Filed 2020·Granted Aug 20, 2024·0 cites·21 claims
- 0968US9745598B2miRNA-regulated differentiation-dependent self-deleting cassetteREGENERON PHARMA·Filed 2016·Granted Aug 29, 2017·0 cites·47 claims
- 1062US2016108360A1Genetic modification of ratsREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1161US2014235933A1Genetic modification of ratsREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1260US2020370054A1Non-human animals having a hexanucleotide repeat expansion in a c9orf72 locusREGENERON PHARMA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →